|
TOP2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.141830E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.696400E-02 |
| Normal-vs-Stage2 |
8.797600E-01 |
| Normal-vs-Stage3 |
1.921800E-01 |
| Normal-vs-Stage4 |
3.022200E-02 |
| Stage1-vs-Stage2 |
4.217700E-02 |
| Stage1-vs-Stage3 |
6.720800E-01 |
| Stage1-vs-Stage4 |
1.685790E-01 |
| Stage2-vs-Stage3 |
1.145010E-01 |
| Stage2-vs-Stage4 |
1.074200E-02 |
| Stage3-vs-Stage4 |
1.702400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.271900E-02 |
| Normal-vs-AfricanAmerican |
3.687200E-01 |
| Normal-vs-Asian |
2.180200E-01 |
| Caucasian-vs-AfricanAmerican |
6.656600E-01 |
| Caucasian-vs-Asian |
4.731600E-01 |
| AfricanAmerican-vs-Asian |
9.920000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.528000E-02 |
| Normal-vs-Female |
1.382570E-01 |
| Male-vs-Female |
5.559800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.904200E-02 |
| Normal-vs-Age(41-60Yrs) |
6.098200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.926420E-01 |
| Normal-vs-Age(81-100Yrs) |
1.422390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.188100E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.732630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.220410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.665990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.367400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.535800E-01 |
| Classical-VS-Follicular |
5.794500E-04 |
| Classical-VS-Other |
5.137200E-01 |
| Classical-VS-Normal |
4.364000E-02 |
| Tall-VS-Follicular |
8.779400E-03 |
| Tall-VS-Other |
3.708000E-01 |
| Tall-VS-Normal |
5.583700E-02 |
| Follicular-VS-Other |
5.908400E-01 |
| Follicular-VS-Normal |
9.968400E-01 |
| Other-VS-Normal |
5.500200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.656600E-01 |
| Normal-vs-N1 |
2.411800E-01 |
| N0-vs-N1 |
8.444400E-01 |
|
|
